News
Sickle Cell Disease is a genetic blood disorder characterised by the presence of sickle-shaped red blood cells, which can block blood flow, cause chronic pain, and lead to a host of physical ...
Among more than 2,000 children with sickle cell anemia, the most severe form of SCD, those treated with hydroxyurea over a prolonged period of time visited the emergency department less frequently ...
Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...
The quality of life of patients with sickle cell anemia is severely compromised similar to or even worse than patients with other chronic diseases such as arthritis. Patients who responded to ...
Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the ...
In a world where certain health conditions dominate headlines and funding priorities, sickle cell disease — a genetic blood ...
New Drug Tested to Reduce Side Effect of 'Half-Matched' Stem Cell Transplants Dec. 5, 2024 — Stem cell transplantation is used to treat several types of blood cancers, but carries the risk of a ...
HealthDay News — For adults with sickle cell disease (SCD), C-reactive protein (CRP) levels increase significantly during the follicular phase of the menstrual cycle, according to a study published ...
Taleah McKnight, 30, also known as Abygail Brooks, Chemory Brooks, Taleah Brooks, Leah Osei, and Leah Javon has an active arrest warrant for theft by deception and theft of services, East Hempfield ...
The U.S. Patent Office has given AB Science notice that it will allow a patent to be issued covering the use of the experimental therapy masitinib for sickle cell disease (SCD). This medical use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results